The landscape of dementia diagnosis has progressed substantially with the advent of refined biomarkers, which include amyloid PET scans, tau imaging, and blood-centered assessments that could detect Alzheimer's pathology a long time just before signs and symptoms emerge. Even though these technological developments signify impressive development in comprehension neurodegenerative cond... https://juliao531nyi1.wikimidpoint.com/user